2022 Jul 11;13(1):4007
AHK-Cu significantly stimulates vascular endothelial growth factor (VEGF), a key driver of angiogenesis, or the formation of new capillaries that deliver oxygen and nutrients to dermal tissue
Haller H, Breilmann P, Schrter M, et al
We aimed to explore flexible management of GLP-1RA therapy when tolerability issues arise, including gastrointestinal (GI) adverse events (AEs), as a potentially important part of overcoming barriers to treatment persistence
3 Empagliflozin (Jardiance) and liraglutide (Victoza) have been shown to reduce cardiovascular and all-cause mortality when added to standard care
RM-718, PL7737 and 710GO all report efficacy with acceptable nonclinical safety profiles, including no evidence of cardiac activation (25, 130)